Wondering about the 2026 cost of tirzepatide with Medicare? Learn if your Part D plan covers Mounjaro vs. Zepbound and how to estimate your costs.

This content is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any new medication or treatment plan.
The conversation around GLP-1 medications has been dominated by one major question for years: how much do they cost? For those on a fixed income, especially Medicare beneficiaries, this question is critical. Tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for weight management, is a powerful tool, but its price tag has put it out of reach for many. This guide breaks down the real cost of tirzepatide with Medicare in 2026. Thanks to significant policy changes this year, brand-name tirzepatide is more accessible than ever before. We will cover every option, from new Medicare programs to cash-pay alternatives.
Before we get into the details, here is a quick look at what you can expect to pay for a one-month supply of tirzepatide. These prices show the vast difference between having coverage and paying out of pocket.
| Payment Method | Medication | Condition | Estimated Monthly Cost (2026) | Notes |
|---|---|---|---|---|
| Medicare Part D (Bridge Program) | Zepbound | Chronic Weight Management | $50 or less | Starts July 1, 2026. For eligible beneficiaries (BMI ≥30 or ≥27 w/ comorbidity). Requires prior authorization. |
| Medicare Part D | Mounjaro | Type 2 Diabetes | ~$50 | Copay due to IRA negotiations. Reaching the $2,000 annual cap makes it free for the rest of the year. |
| Commercial Insurance | Zepbound / Mounjaro | Varies | $25 - $250+ | With Lilly Savings Card, cost can be as low as $25. Highly dependent on your plan's formulary. |
| LillyDirect (Cash Pay) | Zepbound (Vials) | Weight Management | $299 - $699 | Direct-to-patient pricing from the manufacturer, varies by dose. No insurance needed. |
| Online Telehealth Clinic | Compounded Tirzepatide | Weight Management | $299 - $600+ | Prices vary by clinic and dosage. Includes medication, consult, and supplies. |
| Retail / Cash Pay (No Insurance) | Zepbound / Mounjaro | Varies | $1,000 - $1,200 | Full list price at a pharmacy without any insurance or discount programs. |
As you can see, the cost of tirzepatide with Medicare can be surprisingly low if you qualify for the right program. However, understanding which program applies to you is key.
Unsure which path is right for you or if you qualify for these programs? The world of GLP-1s and insurance can be confusing. Take our free 3-minute quiz to get matched with a provider who can review your health history and guide you toward the most affordable options.
For years, Medicare coverage for weight loss medications has been a frustrating dead end for many. Federal law has historically excluded drugs used solely for weight management from Medicare Part D coverage. This meant while Mounjaro was often covered for its approved use in type 2 diabetes, Zepbound for weight loss was not.
However, 2026 marks a turning point. A combination of new government programs and existing cost-saving measures has dramatically changed the financial picture for beneficiaries.
If you are a Medicare beneficiary with a diagnosis of type 2 diabetes, you are in a strong position. Mounjaro is an FDA-approved treatment for this condition and is generally covered by Medicare Part D plans.
Due to the Inflation Reduction Act (IRA), Medicare has been negotiating drug prices directly with manufacturers. As a result, the out-of-pocket copay for Mounjaro for many Part D beneficiaries is capped at around $50 per month in 2026 (Telehealth Ally). This applies after your deductible is met.
Furthermore, the IRA introduced a $2,000 annual out-of-pocket maximum for Part D prescription drugs, which started in 2025. With Mounjaro's high list price (over $1,000 per month), you will likely hit this $2,000 cap within the first few months of the year. Once you hit that cap, your Mounjaro prescription will be $0 for the rest of the calendar year.
According to one analysis, many patients will reach the cap in 3-5 months (PeptidesExplorer). This effectively averages your monthly cost over the year to around $167, but your monthly payments will be higher at the start of the year and then drop to zero. It is important to remember that most Part D plans will require a prior authorization from your doctor to confirm your type 2 diabetes diagnosis before they approve coverage. You can read more about typical tirzepatide cost per month in our related guide.
This is the biggest news for Medicare beneficiaries seeking tirzepatide for weight loss. On July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge program.
This program is designed to provide access to brand-name GLP-1s like Zepbound for chronic weight management before wider coverage models are implemented. According to a report from Telehealth Ally, the Bridge Program caps the copay for Zepbound at a maximum of $50 per month for eligible Medicare beneficiaries.
Eligibility for the $50/month Zepbound program requires:
This program is a massive development. It directly addresses the long-standing gap in Medicare coverage for obesity treatments. For the first time, Medicare beneficiaries can access brand-name Zepbound for weight loss at a predictable and affordable price, a steep drop from the $1,000+ retail cost. The $50 copay applies to all dosages, and sources indicate it is exempt from the Part D deductible (Telehealth Ally). You can explore an overview of Zepbound cost in more detail in our comprehensive guide.
Beyond weight loss, tirzepatide is being studied for and approved for other health conditions. In December 2024, Zepbound received FDA approval for treating obstructive sleep apnea (OSA). Because this is an FDA-approved medical indication, Medicare Part D plans are now covering Zepbound for patients with a documented diagnosis of OSA (GLP3 Planner). The cost structure would be similar to that of Mounjaro for diabetes, falling under the standard Part D copay rules and the $2,000 annual cap.
This provides another pathway to coverage for Medicare patients who may not have diabetes but suffer from OSA, a common comorbidity of obesity.
Even with the new Medicare programs, some individuals may not qualify or might face temporary coverage gaps. If you find yourself needing to pay cash, you are not automatically stuck with the full retail price. Understanding your options is key to managing what does tirzepatide cost on your own.
The standard list price for a one-month supply of Zepbound or Mounjaro at a retail pharmacy typically falls between $1,000 and $1,200 (Doctronic). Paying this amount month after month is not sustainable for most people.
Fortunately, the manufacturer, Eli Lilly, has created a more direct and affordable cash-pay option called LillyDirect. Through this service, patients can order Zepbound directly without using insurance. The pricing is tiered based on the strength of the medication, which is a key factor in the overall tirzepatide dosage cost.
According to Lilly's pricing information and market analysis, single-dose vials of Zepbound through LillyDirect cost:
While still a significant expense, paying $299 for the same medication that costs over $1,000 at the pharmacy is a substantial saving. This option provides a crucial alternative for those who don't have insurance coverage for Zepbound or are waiting for a prior authorization to be approved. This is often a better route than pharmacy discount cards like GoodRx, which may only offer minor discounts on expensive brand-name drugs. For a deeper look at cash prices, see our guide on how much Mounjaro is without insurance.

Another popular path for accessing tirzepatide is through online telehealth clinics that work with compounding pharmacies. Compounded tirzepatide is a version of the medication created by a specialized pharmacy that combines the active pharmaceutical ingredient (tirzepatide) with other ingredients, often a vitamin like B12 or Niacinamide.
This is a legal and common practice when there is a drug shortage, which has frequently been the case for GLP-1s. Because compounding pharmacies are not bound by the brand-name drug's pricing, they can offer the medication at a much lower cost. This makes it a go-to option for people paying out-of-pocket.
The monthly cost for compounded tirzepatide typically ranges from $299 to over $600, depending on the provider and your required dosage. These all-inclusive programs usually bundle the medication, your virtual consultation with a doctor, all necessary supplies (needles, swabs), and shipping.
Here is a comparison of what you might expect from popular online providers in 2026.
| Online Provider | Starting Monthly Price (2026) | Price at Max Dose (Est.) | What's Included |
|---|---|---|---|
| RxFox Partner Clinic A | $299 | ~$599 | Medication, virtual consult, supplies, shipping |
| RxFox Partner Clinic B | $379 | ~$649 | Medication, provider messaging, supplies, shipping |
| Generic Online Clinic C | $399 | ~$750+ | Medication, initial consult only, supplies |
| Premium Service Clinic D | $499 | ~$899 | Medication, dedicated health coach, supplies, app access |
When considering this route, it is vital to choose a reputable platform. Ensure the clinic uses a licensed, US-based pharmacy for its medications. You can learn more about finding a trustworthy source in our guide to the cheapest tirzepatide compounding pharmacy.
Want to see which online clinics are vetted and offer the best value? Our free quiz connects you with top-rated telehealth providers that offer transparent pricing and high-quality compounded medications, helping you find an affordable program that fits your needs.
Navigating the cost of tirzepatide with Medicare or without insurance requires a strategic approach. Here are several effective ways to lower your monthly expense.
Maximize the Medicare GLP-1 Bridge Program: If you are seeking Zepbound for weight loss, this is your number one strategy. Talk to your doctor as soon as possible about submitting a prior authorization based on your BMI. A $50 copay for brand-name Zepbound is currently the best deal available for Medicare beneficiaries without diabetes.
Utilize Your Part D Plan for Mounjaro: If you have type 2 diabetes, ensure your Part D plan covers Mounjaro. Understand your plan's deductible and copay structure. Once you hit the $2,000 annual out-of-pocket maximum, your medication will be free for the remainder of the year. Budgeting for those initial months is key.
Opt for LillyDirect for Cash Pay: If you don't qualify for Medicare coverage or are in a coverage gap, skip the retail pharmacy. Go directly to LillyDirect to access Zepbound vials for $299-$699 per month. This is a guaranteed way to save hundreds compared to the list price.
Consider Compounded Tirzepatide: For many, a monthly cost of $300-$500 for compounded tirzepatide is more manageable than even the LillyDirect pricing, especially at higher doses. It's a reliable alternative if brand-name coverage is not an option. Compare your options to see if this is a good fit.
Look into Medicare Advantage (Part C) Plans: While standard Part D plans follow federal rules, some Medicare Advantage plans may offer supplemental benefits or wellness programs that could help offset costs or provide access to related services. During open enrollment, review your plan's specific formulary and benefits.
Ask About an Appeal: If your prior authorization for Mounjaro or Zepbound is denied, don't give up. You and your doctor have the right to appeal the decision. Often, denials are due to incomplete paperwork and can be overturned with additional documentation.
Check for Other Qualifying Conditions: As new FDA approvals emerge, more pathways to coverage open up. The approval for OSA is a perfect example. Stay in communication with your doctor about your complete health profile, as another condition could make you eligible for coverage.

Whether the monthly expense is "worth it" is a personal calculation that balances finances with health outcomes. Tirzepatide has demonstrated significant success in clinical trials, leading to substantial weight loss and improved glycemic control. These benefits can have a ripple effect on your overall health.
Investing in a medication like tirzepatide could potentially reduce long-term healthcare costs associated with obesity-related conditions like heart disease, joint problems, and even certain cancers. Many users also report improved mobility, energy levels, and overall quality of life.
However, the cost is a real and valid concern. For some, a $50 monthly copay through a Medicare program is a clear win. For others, a $400 monthly cash-pay expense for a compounded version requires careful budgeting. It is a decision that should be made in partnership with your healthcare provider, who can help you weigh the potential health benefits against the financial reality. Comparing its effectiveness to other options, like in our semaglutide vs. tirzepatide analysis, can also provide context.
Ultimately, the new programs and cash-pay options available in 2026 have made tirzepatide more accessible than ever. The key is knowing which path to take.
Ready to explore your options and find a plan that fits your budget? Take our free 3-minute quiz to get matched with a licensed provider who can help you determine the most affordable and effective treatment path.
For eligible Medicare beneficiaries, the monthly cost is approximately $50. This applies to Mounjaro for type 2 diabetes and, as of July 1, 2026, to Zepbound for chronic weight management through the new Medicare GLP-1 Bridge program. This price requires meeting eligibility criteria and getting prior authorization.
Yes. While Part D statute historically excludes weight-loss-only drugs, the Medicare GLP-1 Bridge program, launched July 1, 2026, provides coverage. It caps the monthly copay for Zepbound at $50 for beneficiaries with a BMI of 30 or higher (or 27 with a comorbidity).
If you are denied coverage, first work with your doctor to appeal the decision. If the appeal is unsuccessful, your best options are paying cash through LillyDirect (starting at $299/month for brand-name Zepbound) or exploring compounded tirzepatide from an online clinic (also starting around $299/month).
The cheapest way is to qualify for one of the programs that caps your copay at around $50 per month. This includes using your Part D plan for Mounjaro (with T2D) or enrolling in the GLP-1 Bridge program for Zepbound (for weight management).
No. For both the Mounjaro Part D coverage and the Zepbound Bridge Program, the monthly copay (e.g., ~$50) is typically a fixed amount, regardless of whether you are on a 2.5mg starting dose or a 15mg maintenance dose. Your monthly out-of-pocket cost should remain stable as your dosage increases.
Contributing to evidence-based peptide education and provider transparency.
We don't sell peptides. Tell us your goals and we'll connect you with a vetted provider who can figure out what actually makes sense for you.
See what's right for youSearching for 'peptides near me for weight loss'? Our guide explains how to find a reputable clinic, what questions to ask, and how to get started safely.
GLP-1 Weight LossThe Zepbound cost can range from $25 to over $1,000. Learn your true out-of-pocket expense based on your insurance plan and how to access savings programs.
GLP-1 Weight LossThe Wegovy cost can be confusing. This guide breaks down what you'll actually pay in 2026 with or without insurance and shares ways to make it affordable.